Hamilton Oh, then a graduate student in Tony Wyss-Coray’s lab at Stanford Medicine, helped develop a blood test so precise it can estimate the biological age of 11 separate organ systems—down to how fast your brain or kidneys are aging—using just a single blood draw. The test analyzes nearly 3,000 proteins, some of which serve as molecular fingerprints pointing directly to specific organs. For the first time, scientists can now peer inside the body and see not just how old you are on paper, but which organs are aging faster or slower than expected—and predict disease risk up to a decade before symptoms appear.
This breakthrough matters because chronological age doesn’t tell the full story of health. Two 55-year-olds can have wildly different risks for heart disease, dementia, or kidney failure, depending on how their internal organs are aging. The new test, based on data from 44,498 participants in the UK Biobank tracked for up to 17 years, uses protein patterns to assign a biological age to each organ. When an organ’s protein signature deviates by more than 1.5 standard deviations from the norm, it’s classified as “extremely aged” or “extremely youthful.” One in three people in the study had at least one organ in the “extremely aged” category, and one in four had multiple organs aging at outlier rates.
The implications are profound. A person with an “extremely aged” brain, for example, is at significantly higher risk for neurodegenerative disease and earlier mortality—even if their heart or liver appears younger. Wyss-Coray, the D. H. Chen Professor II and senior author of the study published July 9 in Nature Medicine, puts it plainly: “The brain is the gatekeeper of longevity.” The team found that brain biological age was the strongest predictor of overall survival, more so than any other organ. But the test isn’t just about risk—it could guide prevention. Someone with an aging pancreas might be steered toward earlier diabetes screening; someone with aging arteries could receive early cardiovascular interventions.
The technology hinges on a commercial platform that measures nearly 3,000 proteins in the blood, about 15% of which originate predominantly in one organ. By comparing individual protein levels to age-adjusted baselines across thousands of people, the algorithm detects subtle shifts long before clinical symptoms emerge. This isn’t science fiction—it’s data-driven medicine with the potential to shift healthcare from reactive to proactive.
As the team refines the test for broader use, the vision is clear: a future where annual checkups include organ-specific aging reports, empowering people to protect their most vulnerable systems years before disease takes hold.